Gene therapy for cystic fibrosis: challenges and future directions.

This publication has 76 references indexed in Scilit:

• [Ca2+]i inhibition of Ca2+ release-activated Ca2+ influx underlies agonist- and thapsigargin-induced [Ca2+]i oscillations in salivary acinar cells.
  Journal of Biological Chemistry, 1994
• Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans
  Nature, 1994
• The role of CD40 in the regulation of humoral and cell-mediated immunity
  Immunology Today, 1994
• Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
  Nature Genetics, 1994
• Acute Responses of Non-Human Primates to Airway Delivery of an Adenovirus Vector Containing the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA
  Human Gene Therapy, 1994
• Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis
  Nature Genetics, 1994
• In VivoEvaluation of the Safety of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Lung
  Human Gene Therapy, 1994
• Gene Therapy for Cystic Fibrosis Using E1-Deleted Adenovirus: A Phase I Trial in the Nasal Cavity. University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  Human Gene Therapy, 1994
• Correction of cAMP-Stimulated Fluid Secretion in Cystic Fibrosis Airway Epithelia: Efficiency of Adenovirus-Mediated Gene Transfer In Vitro
  Human Gene Therapy, 1994
• Gene Therapy of Cystic Fibrosis Lung Disease Using E1 Deleted Adenoviruses: A Phase I Trial. University of Michigan, Ann Arbor, Michigan and University of Pennsylvania, Philadelphia, Pennsylvania
  Human Gene Therapy, 1994